Search by Drug Name or NDC
NDC 75834-0272-90 SILDENAFIL CITRATE 25 mg/1 Details
SILDENAFIL CITRATE 25 mg/1
SILDENAFIL CITRATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NIVAGEN PHARMACEUTICALS, INC.. The primary component is SILDENAFIL CITRATE.
MedlinePlus Drug Summary
Sildenafil (Viagra) is used to treat erectile dysfunction (impotence; inability to get or keep an erection) in men. Sildenafil (Revatio) is used to improve the ability to exercise in adults with pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Children should not usually take sildenafil, but in some cases, a doctor may decide that sildenafil (Revatio) is the best medication to treat a child's condition. Sildenafil is in a class of medications called phosphodiesterase (PDE) inhibitors. Sildenafil treats erectile dysfunction by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Sildenafil treats PAH by relaxing the blood vessels in the lungs to allow blood to flow easily. If you are taking sildenafil to treat erectile dysfunction, you should know that it does not cure erectile dysfunction or increase sexual desire. Sildenafil does not prevent pregnancy or the spread of sexually transmitted diseases such as human immunodeficiency virus (HIV).
Related Packages: 75834-0272-90Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Sildenafil
Product Information
| NDC | 75834-0272 |
|---|---|
| Product ID | 75834-272_0cf0c12a-c9b3-658d-e063-6294a90a1a32 |
| Associated GPIs | |
| GCN Sequence Number | 039189 |
| GCN Sequence Number Description | sildenafil citrate TABLET 25 MG ORAL |
| HIC3 | F2A |
| HIC3 Description | DRUGS TO TREAT ERECTILE DYSFUNCTION (ED) |
| GCN | 57901 |
| HICL Sequence Number | 018084 |
| HICL Sequence Number Description | SILDENAFIL CITRATE |
| Brand/Generic | Generic |
| Proprietary Name | SILDENAFIL CITRATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SILDENAFIL CITRATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | SILDENAFIL CITRATE |
| Labeler Name | NIVAGEN PHARMACEUTICALS, INC. |
| Pharmaceutical Class | Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209302 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 75834-0272-90 (75834027290)
| NDC Package Code | 75834-272-90 |
|---|---|
| Billing NDC | 75834027290 |
| Package | 90 TABLET in 1 BOTTLE (75834-272-90) |
| Marketing Start Date | 2021-06-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |